One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Proposals for the rheumatological use of JAK inhibitors
Francesco Ciccia & Roberto CaporaliÂ
doi : 10.1038/s41584-023-01068-3
Volume 20 Issue 2, February 2024
New genes, pathways and therapeutic targets in autoinflammatory diseases
Riccardo Papa & Marco GattornoÂ
Emerging therapeutic options for refractory gout
Kanon Jatuworapruk & Worawit LouthrenooÂ
Large language models: rheumatologists’ newest colleagues?
Vincenzo Venerito & Latika GuptaÂ
Advances in the treatment of polymyalgia rheumatica and giant cell arteritis
Lindsay Lally & Robert SpieraÂ
Exploring the latest advances in axial spondyloarthritis management
Diego Benavent & Victoria Navarro-CompánÂ
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
Carlisle R. DeJulius, Bonnie L. Walton, Juan M. Colazo, Richard d’Arcy, Nora Francini, Jonathan M. Brunger & Craig L. DuvallÂ
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
Zoltán Szekanecz, Maya H. Buch, Christina Charles-Schoeman, James Galloway, George A. Karpouzas, Lars Erik Kristensen, Steven R. Ytterberg, Attila Hamar & Roy FleischmannÂ
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrovic, Dennis McGonagle & Roberto GiacomelliÂ
Author Correction: New genes, pathways and therapeutic targets in autoinflammatory diseases
Riccardo Papa & Marco GattornoÂ
